EHA 2022 | Managing ALL patients who relapse after transplantation
Sabina Chiaretti
• 12 Jun 2022
Sabina Chiaretti, MD, PhD, Sapienza University of Rome, Rome, Italy, shares some insights into the management of patients with acute lymphoblastic leukemia (ALL) who relapse after transplantation, including the promise of monoclonal antibodies and CAR-T therapy. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
Disclosures
Amgen, Incyte, Novartis, AbbVie, Gilead
